Cover Image.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24295
- Publication type:
- Article
Works matching IS 24758817 AND DT 2022 AND VI 114 AND IP 5
Results: 8
1
2
Issue Information.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24294
- Publication type:
- Article
3
Linearized teixobactin is inactive and after sequence enhancement, kills methicillin‐resistant Staphylococcus aureus via a different mechanism.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24269
- By:
- Publication type:
- Article
4
A shelf stable Fmoc hydrazine resin for the synthesis of peptide hydrazides.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24268
- By:
- Publication type:
- Article
5
Computational design of stapled peptide inhibitor against SARS‐CoV‐2 receptor binding domain.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24267
- By:
- Publication type:
- Article
6
Structured cyclic peptide mimics by chemical ligation.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24266
- By:
- Publication type:
- Article
7
A refined photo‐switchable cyclic peptide scaffold for use in β‐turn activation.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24265
- By:
- Publication type:
- Article
8
Application of a triple‐helical peptide inhibitor of MMP‐2/MMP‐9 to examine T‐cell activation in experimental autoimmune encephalomyelitis.
- Published in:
- Peptide Science, 2022, v. 114, n. 5, p. 1, doi. 10.1002/pep2.24262
- By:
- Publication type:
- Article